Skip to content

Acupuncture and Moxibustion in the Treatment of Active Crohn's Disease: A Randomized Controlled Study

Joos et al. · Digestion · 2004

🔬Controlled RCT👥n = 51 patientsModerate Impact

Evidence Level

MODERATE
72/ 100
Quality
4/5
Sample
3/5
Replication
3/5
🎯

OBJECTIVE

To investigate the efficacy of traditional Chinese acupuncture in the treatment of active Crohn's disease

👥

WHO

51 patients with mild to moderately active Crohn's disease

⏱️

DURATION

4 weeks of treatment with 12-week follow-up

📍

POINTS

BL-20, CV-12, ST-36, ST-25, SP-15 (basic) + individualized points based on TCM

🔬 Study Design

51participants
randomization

TCM Group

n=27

Traditional Chinese acupuncture + moxibustion

Control Group

n=24

Superficial acupuncture at non-specific points

⏱️ Duration: 4 weeks of treatment, 12 weeks of follow-up

📊 Results in numbers

87 points

CDAI reduction - TCM

39 points

CDAI reduction - Control

p = 0.003

Statistical significance

0%

Remission or near-remission TCM

Percentage highlights

56%
Remission or near-remission TCM

📊 Outcome Comparison

Improvement in CDAI (points)

TCM
87
Control
39

Overall well-being (improvement on VAS)

TCM
2.7
Control
1.1
💬 What does this mean for you?

This study shows that traditional Chinese acupuncture may help people with active Crohn's disease by reducing disease activity nearly twice as much as a control treatment. Patients who received true acupuncture reported better overall well-being and some inflammation markers improved, suggesting that acupuncture may be a useful complementary treatment.

📝

Article summary

Plain-language narrative summary

Crohn's disease is a chronic inflammatory condition that affects the digestive system, causing abdominal pain, diarrhea, and other symptoms that significantly impact patients' quality of life. In Western countries, an increasing number of people with chronic diseases, including Crohn's disease, have sought complementary treatment methods, with particular interest in acupuncture. In traditional Chinese medicine, there is a condition called "damp-heat diarrhea" that shares clinical features similar to inflammatory bowel diseases, and is traditionally treated with personalized acupuncture based on each patient's individual diagnosis.

This pioneering study aimed to scientifically investigate the efficacy of traditional Chinese acupuncture in treating active Crohn's disease. The German researchers conducted a randomized controlled clinical trial between 1998 and 1999, including 51 patients with mild to moderately active Crohn's disease. Participants were randomly divided into two groups: 27 received traditional Chinese acupuncture (including moxibustion when indicated), and 24 received control acupuncture with needles inserted superficially at points unrelated to Chinese medicine principles. All patients received 10 sessions of 30 minutes over four weeks and were followed for an additional 12 weeks.

The primary endpoint was change in the Crohn's Disease Activity Index, an established scale measuring symptom severity. Quality of life, overall well-being, and blood markers of inflammation were also assessed.

Results demonstrated significantly greater improvement in the group receiving traditional Chinese acupuncture. The disease activity index decreased from 250 to 163 points in the traditional acupuncture group, compared with a reduction from 220 to 181 points in the control group. This difference not only reached statistical significance but also represented a clinically relevant benefit for patients. The improvement was accompanied by a greater sense of overall well-being in the traditional acupuncture group, and the benefits remained stable throughout the 12-week follow-up period.

In terms of disease remission, 41% of patients in the traditional acupuncture group achieved complete or near-complete remission, compared with 33% of the control group. Additionally, only the traditional acupuncture group showed a significant reduction in alpha-1-acid glycoprotein, a specific laboratory marker of intestinal inflammation.

These findings have important clinical implications for both patients and healthcare professionals. For patients with Crohn's disease, acupuncture offers a complementary therapeutic option that may provide significant symptom relief with minimal side effects. During the study, no clinically relevant adverse reactions were observed — only isolated cases of mild headache or temporary low back discomfort. The high patient adherence to treatment and the absence of serious side effects represent notable advantages compared with many pharmacological therapies.

For healthcare professionals, especially gastroenterologists, these results suggest that acupuncture may be considered a valuable adjunctive therapy, potentially allowing dose reduction of corticosteroids or accelerating their tapering, which frequently cause significant adverse effects with prolonged use.

The study has several important limitations that should be considered when interpreting the results. The sample size was relatively small, chosen primarily for ethical reasons to avoid exposing a large number of patients to potentially ineffective treatments. The dropout rate was higher in the control group, which may have influenced the results, although different statistical analyses confirmed the robustness of the findings. Complete blinding of the researchers was not possible because of organizational issues, although each patient was evaluated by a different therapist from the one who administered the treatment.

Additionally, the molecular mechanisms by which acupuncture exerts its beneficial effects in Crohn's disease remain unknown, although modulation of the immune system and the autonomic nervous system is suspected. Future studies with larger samples, longer follow-up periods, and investigation of mechanisms of action are needed to confirm these promising findings and definitively establish the role of acupuncture in the management of Crohn's disease.

Strengths

  • 1First controlled study of acupuncture in Crohn's disease
  • 2Use of traditional TCM principles
  • 312-week follow-up
  • 4Evaluation of multiple outcomes including laboratory markers
  • 5No significant adverse effects
⚠️

Limitations

  • 1Small sample size
  • 2Inability to blind the acupuncturists
  • 3High dropout rate in the control group
  • 4Difficulty in creating an adequate placebo control for acupuncture
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

Crohn's disease imposes on the gastroenterologist the permanent challenge of inflammatory control with the lowest cost in adverse effects — especially when dealing with mild to moderately active forms, where immediate escalation to biologics is not always justified. This work by Joos et al. opens a relevant clinical window by demonstrating that traditional Chinese acupuncture, conducted according to TCM diagnostic principles, produces a clinically expressive reduction of the CDAI in four weeks, with sustained benefit over twelve weeks of follow-up. For the physician who integrates acupuncture into clinical practice, the most immediate scenario for application is the patient on a corticosteroid in the tapering phase, or those with mild to moderate disease refractory to aminosalicylates, who seek an alternative before advancing in therapeutic escalation. The young population of reproductive age, concerned about teratogenicity and prolonged immunosuppression, represents another group with significant potential for benefit.

Notable Findings

The 87-point reduction in CDAI in the traditional acupuncture group, against 39 points in the control group, with p = 0.003, represents a difference that exceeds the threshold of clinical relevance conventionally accepted for this scale. Particularly noteworthy is the behavior of alpha-1-acid glycoprotein — an acute-phase marker of intestinal inflammation — which showed a significant reduction exclusively in the traditional acupuncture group, suggesting a modulatory action on the local inflammatory microenvironment, not just an effect on symptomatic perception. The 56% rate of remission or near-remission in the active group is notable for a protocol of only ten sessions in four weeks. Another finding deserving attention is the durability of the response: improvement remained stable throughout the entire twelve-week follow-up, which rules out the hypothesis of a purely acute effect or one due to non-specific placebo response.

From My Experience

In my practice, I have incorporated acupuncture as an adjuvant in inflammatory bowel diseases for many years, and the patterns I observe in the clinic align well with what Joos et al. documented. I usually see the first signs of response — reduction in stool frequency and improvement in overall well-being — between the third and fifth sessions, which guides patient expectations from the beginning. For the active phase, I work with cycles of ten to twelve sessions, then adjust to monthly maintenance according to clinical evolution. TCM pattern diagnosis — especially the damp-heat pattern with Large Intestine involvement — guides point selection; ST-25, ST-36, SP-9, and ST-37 frequently appear in the protocols I use, combined with moxibustion when there are signs of Yang deficiency. Patients with predominant anxious manifestations and associated dysautonomia respond particularly well. In cases with established indication for biologic therapy, I do not replace it, but acupuncture has proven useful in controlling residual symptoms during the early therapeutic window of these agents.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

Digestion · 2004

DOI: 10.1159/000078151

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.